Track 21: HIV gene therapy

In patients with HIV, highly active antiretroviral therapy significantly increases survival. The existence of drug-resistant escape mutations, cumulative toxicities, and partial immunological recovery can make lifelong treatment more difficult as a result of the persistence of HIV in reservoirs. In the absence of long-term antiviral medication, cell and gene therapies hold the potential of avoiding progressive HIV infection by blocking HIV replication.


    Related Conference of Track 21: HIV gene therapy

    February 24-25, 2025

    19th International Conference on Regenerative Repair and Medicine

    Madrid, Spain
    April 03-04, 2025

    15th International Conference on Human Genetics and Genetic Diseases

    Madrid, Spain
    April 03-04, 2025

    18th International Conference on Genomics & Pharmacogenomics

    Madrid, Spain
    April 14-15, 2025

    8th Annual Conference on Stem Cell and Regenerative Medicine

    Budapest, Hungary
    April 29-30, 2025

    3rd International Conference on Cell Science and Molecular Biology

    Barcelona, Spain
    May 19-20, 2025

    8th Global Conference on Cell and Gene Therapy

    Singapore City, Singapore
    June 12-13, 2025

    13th World Congress on Human Genetics and Genetic Diseases

    London, UK
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany
    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    October 27-28, 2025

    20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Madrid, Spain

    Track 21: HIV gene therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in